Bile secretion is regulated by different signaling transduction pathways including
protein kinase C (PKC). However, the role of different PKC
isoforms for bile formation is still controversial. This study investigates the effects of PKC
isoform selective activators and inhibitors on PKC translocation, bile secretion,
bile acid uptake, and subcellular transporter localization in rat liver, isolated rat hepatocytes and in HepG2 cells. In rat liver activation of Ca(2+)-dependent cPKCalpha and Ca(2+)-independent PKCepsilon by
phorbol 12-myristate 13-acetate (PMA, 10nmol/liter) is associated with their translocation to the plasma membrane. PMA also induced translocation of the cloned rat PKCepsilon fused to a yellow fluorescent
protein (YFP), which was transfected into HepG2 cells. In the perfused liver, PMA induced marked
cholestasis. The PKC inhibitors Gö6850 (1 micromol/liter) and Gö6976 (0.2 micromol/liter), a selective inhibitor of Ca(2+)-dependent PKC
isoforms, diminished the PMA effect by 50 and 60%, respectively.
Thymeleatoxin (Ttx,) a selective activator of Ca(2+)-dependent cPKCs, did not translocate rat PKCepsilon-YFP transfected in HepG2 cells. However, Ttx (0.5-10 nmol/liter) induced
cholestasis similar to PMA and led to a retrieval of Bsep from the canalicular membrane in rat liver while
taurocholate-uptake in isolated hepatocytes was not affected. Gö6976 completely blocked the cholestatic effect of Ttx but had no effect on
tauroursodeoxycholate-induced choleresis. The data identify Ca(2+)-dependent PKC
isoforms as inducers of
cholestasis. This is mainly due to inhibition of
taurocholate excretion involving transporter retrieval from the canalicular membrane.